BioSpace News Archive

llinois-based Gateway Foundation (gatewayfoundation.org) announces that Karen Wolownik Albert, Executive Director of Gateway Foundation Lake Villa, is the 2018 recipient of the prestigious Dr. C. Vincent Bakeman Memorial Award.

he American Board of Medical Specialties (ABMS) will convene more than 500 professionals from across the health care spectrum at ABMS Conference 2018 on Sept. 24-26.

Along with AT&T*, Hanger, Inc. (OTC PINK: HNGR) today announced the two companies have developed a trailblazing proof of concept for the industry’s first standalone, network-connected device for prosthetic limbs.

Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization, the Almac Group, is delighted to invite participants from the Biopharma Industry to join its fourth consecutive North American and seventh global “lunch and learn” seminar this year, building on its unique global knowledge share series.

Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, is making a $100,000 contribution to the American Nephrology Nurses Association (ANNA), a professional nursing organization with more than 8,500 members

4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, today announced that it completed a private placement of shares of its Series A Preferred Stock earlier this week, resulting in total gross proceeds of approximately $17 million.

More Democrats are lining up behind “Medicare for All” as the midterm elections approach, but the idea under different names has been proposed repeatedly since 1942, as shown in the timeline outlined in the fall issue of the Journal of American Physicians and Surgeons by Jeremy Snavely.

Eli Lilly and Company (NYSE: LLY) announced that it will present new data for Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab at the 27th annual European Academy of Dermatology and Venereology (EADV) Congress taking place Sep. 12-16, 2018, in Paris, France.

Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the United States Court of Appeals for the Federal Circuit, by a 2-1 vote, has upheld the United States District Court for the District of Delaware’s decision to invalidate four AMPYRA patents.

Alabama Attorney General Steve Marshall will be joining Pathway Healthcare (www.pathwayhealthcare.com) for the grand opening of its new office location on Monday, September 10th.